Strategies for identification and clinical evaluation of promising chemopreventive agents.
Oncology (Williston Park, NY), 1996 - europepmc.org
Strategies for chemopreventative drug development are based on the use of well-
characterized agents, intermediate biomarkers correlating to cancer incidence, and suitable …
characterized agents, intermediate biomarkers correlating to cancer incidence, and suitable …
Strategies for identification and clinical evaluation of promising chemopreventive agents
GJ Kelloff, ET Hawk, JA Crowell… - … (Williston Park, NY …, 1996 - pubmed.ncbi.nlm.nih.gov
Strategies for chemopreventative drug development are based on the use of well-
characterized agents, intermediate biomarkers correlating to cancer incidence, and suitable …
characterized agents, intermediate biomarkers correlating to cancer incidence, and suitable …
Strategies for identification and clinical evaluation of promising chemopreventive agents
GJ Kelloff, ET Hawk, JA Crowell… - …, 1996 - mdanderson.elsevierpure.com
Strategies for chemopreventative drug development are based on the use of well-
characterized agents, intermediate biomarkers correlating to cancer incidence, and suitable …
characterized agents, intermediate biomarkers correlating to cancer incidence, and suitable …